Brief: Opregen® Clinical Data Presented At 125Th Annual American Academy Of Ophthalmology Meeting

Lineage Cell Therapeutics

15/11/2021 13:59

Nov 15 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * OPREGEN® CLINICAL DATA PRESENTED AT 125TH ANNUAL AMERICAN
ACADEMY OF OPHTHALMOLOGY MEETING BY MICHAEL S. IP, M.D.
    * LINEAGE CELL THERAPEUTICS INC - STATISTICALLY SIGNIFICANT
DIFFERENCES IN VISUAL ACUITY CONTINUE TO BE OBSERVED
    * LINEAGE CELL - ALL THREE CASES OF RETINAL RESTORATION HAVE
SHOWN
EVIDENCE OF MARKEDLY SMALLER AREAS OF ATROPHY AT 12 MONTHS
POST-TREATMENT
    * LINEAGE CELL THERAPEUTICS INC - OPREGEN HAS BEEN WELL
TOLERATED
TO DATE AND THERE HAVE BEEN NO NEW, UNEXPECTED OCULAR OR
SYSTEMIC ADVERSE EVENTS

Source text for Eikon:  ID:nBw1JY0yRa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))